# Levothyroxine Sodium

NDC: 24201-002
Generic name: LEVOTHYROXINE SODIUM
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20221115

FDA application: NDA214253

## Active ingredients

- LEVOTHYROXINE SODIUM: 100 ug/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"24201-002"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=24201-002
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6279390b-ee61-4ef9-ac15-25537ca783c1